Assessing fetal lung maturation by the foam stability index test

Area of Science:

• Neonatal Medicine
• Biochemistry
• Pulmonary Medicine

Background:

• Amniotic fluid surfactant is crucial for lung maturation in newborns.
• Assessing surfactant's surface tension lowering ability is vital for predicting neonatal respiratory outcomes.
• Existing methods like the L/S ratio have limitations in predicting neonatal respiratory distress.

Purpose of the Study:

• To develop and evaluate a novel assay, the Foam Stability Index (FSI) test, for quantifying amniotic fluid surfactant function.
• To compare the predictive value of the FSI test with the L/S ratio for neonatal respiratory diseases.

Main Methods:

• The FSI test measures the highest ethanol volume fraction allowing stable foam formation in amniotic fluid.
• Amniotic fluid specimens from 59 patients were analyzed using the FSI test.
• The L/S ratio was concurrently measured in 50 of these specimens.

Main Results:

• No cases of hyaline membrane disease (HMD) or transient tachypnea of the newborn (TTNB) were observed with FSI values > 0.47.
• Two cases of HMD were associated with L/S ratios of 2.5 and 2.8.
• The FSI test demonstrated potential in identifying low risk for neonatal respiratory complications.

Conclusions:

• The FSI test is a promising assay for evaluating amniotic fluid surfactant function.
• FSI values > 0.47 appear to reliably predict the absence of HMD and TTNB.
• The FSI test may offer a valuable alternative or adjunct to the L/S ratio in assessing fetal lung maturity.